171 related articles for article (PubMed ID: 34412944)
1. Characterization of Benign and Malignant Pancreatic Lesions with DECT Quantitative Metrics and Radiomics.
Ebrahimian S; Singh R; Netaji A; Madhusudhan KS; Homayounieh F; Primak A; Lades F; Saini S; Kalra MK; Sharma S
Acad Radiol; 2022 May; 29(5):705-713. PubMed ID: 34412944
[TBL] [Abstract][Full Text] [Related]
2. Semiautomatic Segmentation and Radiomics for Dual-Energy CT: A Pilot Study to Differentiate Benign and Malignant Hepatic Lesions.
Homayounieh F; Singh R; Nitiwarangkul C; Lades F; Schmidt B; Sedlmair M; Saini S; Kalra MK
AJR Am J Roentgenol; 2020 Aug; 215(2):398-405. PubMed ID: 32406776
[No Abstract] [Full Text] [Related]
3. Dual-energy CT in differentiating benign sinonasal lesions from malignant ones: comparison with simulated single-energy CT, conventional MRI, and DWI.
Wang P; Tang Z; Xiao Z; Hong R; Wang R; Wang Y; Zhan Y
Eur Radiol; 2022 Feb; 32(2):1095-1105. PubMed ID: 34427744
[TBL] [Abstract][Full Text] [Related]
4. Imaging biomarkers to stratify lymph node metastases in abdominal CT - Is radiomics superior to dual-energy material decomposition?
Mahmoudi S; Koch V; Santos DPD; Ackermann J; Grünewald LD; Weitkamp I; Yel I; Martin SS; Albrecht MH; Scholtz JE; Vogl TJ; Bernatz S
Eur J Radiol Open; 2023; 10():100459. PubMed ID: 36561422
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric detection and outcome prediction of pancreatic cancer involving dual-energy CT, diffusion-weighted MRI, and radiomics.
Koch V; Weitzer N; Dos Santos DP; Gruenewald LD; Mahmoudi S; Martin SS; Eichler K; Bernatz S; Gruber-Rouh T; Booz C; Hammerstingl RM; Biciusca T; Rosbach N; Gökduman A; D'Angelo T; Finkelmeier F; Yel I; Alizadeh LS; Sommer CM; Cengiz D; Vogl TJ; Albrecht MH
Cancer Imaging; 2023 Apr; 23(1):38. PubMed ID: 37072856
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric Evaluation of Radiomics Features and Dual-Energy CT Iodine Maps for Discrimination and Outcome Prediction of Thymic Masses.
Mahmoudi S; Gruenewald LD; Eichler K; Althoff FC; Martin SS; Bernatz S; Booz C; Yel I; Kinzler MN; Ziegengeist NS; Torgashov K; Mohammed H; Geyer T; Scholtz JE; Hammerstingl RM; Weber C; Hardt SE; Sommer CM; Gruber-Rouh T; Leistner DM; Vogl TJ; Koch V
Acad Radiol; 2023 Dec; 30(12):3010-3021. PubMed ID: 37105804
[TBL] [Abstract][Full Text] [Related]
7. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
8. A Machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma.
Brendlin AS; Peisen F; Almansour H; Afat S; Eigentler T; Amaral T; Faby S; Calvarons AF; Nikolaou K; Othman AE
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34795006
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of adrenal adenomas from adrenal metastases in single-phased staging dual-energy CT and radiomics.
Winkelmann MT; Gassenmaier S; Walter SS; Artzner C; Lades F; Faby S; Nikolaou K; Bongers MN
Diagn Interv Radiol; 2022 May; 28(3):208-216. PubMed ID: 35748202
[TBL] [Abstract][Full Text] [Related]
10. Comparison of radiomics models and dual-energy material decomposition to decipher abdominal lymphoma in contrast-enhanced CT.
Bernatz S; Koch V; Dos Santos DP; Ackermann J; Grünewald LD; Weitkamp I; Yel I; Martin SS; Lenga L; Scholtz JE; Vogl TJ; Mahmoudi S
Int J Comput Assist Radiol Surg; 2023 Oct; 18(10):1829-1839. PubMed ID: 36877288
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.
Patel BN; Rosenberg M; Vernuccio F; Ramirez-Giraldo JC; Nelson R; Farjat A; Marin D
AJR Am J Roentgenol; 2018 Sep; 211(3):571-579. PubMed ID: 30040464
[TBL] [Abstract][Full Text] [Related]
12. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
13. Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?
Digumarthy SR; Padole AM; Rastogi S; Price M; Mooradian MJ; Sequist LV; Kalra MK
Cancer Imaging; 2019 Jun; 19(1):36. PubMed ID: 31182167
[TBL] [Abstract][Full Text] [Related]
14. Material density iodine images in dual-energy CT: Detection and characterization of hypervascular liver lesions compared to magnetic resonance imaging.
Muenzel D; Lo GC; Yu HS; Parakh A; Patino M; Kambadakone A; Rummeny EJ; Sahani DV
Eur J Radiol; 2017 Oct; 95():300-306. PubMed ID: 28987684
[TBL] [Abstract][Full Text] [Related]
15. The value of radiomics based on dual-energy CT for differentiating benign from malignant solitary pulmonary nodules.
Liang G; Yu W; Liu SQ; Xie MG; Liu M
BMC Med Imaging; 2022 May; 22(1):95. PubMed ID: 35597900
[TBL] [Abstract][Full Text] [Related]
16. Value of spectral detector computed tomography for assessment of pancreatic lesions.
El Kayal N; Lennartz S; Ekdawi S; Holz J; Slebocki K; Haneder S; Wybranski C; Mohallel A; Eid M; Grüll H; Persigehl T; Borggrefe J; Maintz D; Heneweer C
Eur J Radiol; 2019 Sep; 118():215-222. PubMed ID: 31439245
[TBL] [Abstract][Full Text] [Related]
17. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.
Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
[TBL] [Abstract][Full Text] [Related]
18. Can radiomic analysis of a single-phase dual-energy CT improve the diagnostic accuracy of differentiating enhancing from non-enhancing small renal lesions?
Ding Y; Meyer M; Lyu P; Rigiroli F; Ramirez-Giraldo JC; Lafata K; Yang S; Marin D
Acta Radiol; 2022 Jun; 63(6):828-838. PubMed ID: 33878931
[TBL] [Abstract][Full Text] [Related]
19. Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer.
Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
Quant Imaging Med Surg; 2021 May; 11(5):1946-1957. PubMed ID: 33936977
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of malignant from benign orbital tumours using dual-energy CT.
Luo S; Sha Y; Wu J; Lin N; Pan Y; Zhang F; Huang W
Clin Radiol; 2022 Apr; 77(4):307-313. PubMed ID: 35094818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
